NASDAQ:CVET - Covetrus Stock Price, Forecast & News

Covetrus trades on the NASDAQ under the ticker symbol "CVET."

Covetrus Inc (NASDAQ:CVET) announced its earnings results on Tuesday, November, 12th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.09. The business earned $1.02 billion during the quarter, compared to analyst estimates of $963.69 million. Covetrus had a negative net margin of 23.15% and a positive return on equity of 4.26%. The firm's quarterly revenue was up 10.3% on a year-over-year basis. View Covetrus' Earnings History.

Covetrus is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Covetrus.

8 brokerages have issued 1 year price targets for Covetrus' shares. Their forecasts range from $11.00 to $21.00. On average, they anticipate Covetrus' stock price to reach $15.25 in the next year. This suggests a possible upside of 1.6% from the stock's current price. View Analyst Price Targets for Covetrus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covetrus in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Covetrus.

Headlines about CVET stock have been trending somewhat positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Covetrus earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Covetrus.

Covetrus saw a increase in short interest in December. As of December 31st, there was short interest totalling 15,270,000 shares, an increase of 9.1% from the December 15th total of 13,990,000 shares. Based on an average daily trading volume, of 2,270,000 shares, the short-interest ratio is presently 6.7 days. Currently, 15.7% of the shares of the company are sold short. View Covetrus' Current Options Chain.

Some companies that are related to Covetrus include Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Covetrus investors own include Uber Technologies (UBER), Century Aluminum (CENX), IDEXX Laboratories (IDXX), RealReal (REAL), SVMK (SVMK), Chewy (CHWY), Evolent Health (EVH), Tapestry (TPR), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Covetrus' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.03%), Alpine Global Management LLC (0.02%), Arden Trust Co (0.01%), Nisa Investment Advisors LLC (0.01%) and M&R Capital Management Inc. (0.00%). Company insiders that own Covetrus stock include Benjamin Shaw, Betsy S Atkins, David Christopher Dollar, Erin Powers Brennan and Timothy Ludlow. View Institutional Ownership Trends for Covetrus.

CVET stock was sold by a variety of institutional investors in the last quarter, including M&R Capital Management Inc. and Nisa Investment Advisors LLC. Company insiders that have sold Covetrus company stock in the last year include Betsy S Atkins, David Christopher Dollar and Timothy Ludlow. View Insider Buying and Selling for Covetrus.

CVET stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Alpine Global Management LLC, Arden Trust Co and Louisiana State Employees Retirement System. Company insiders that have bought Covetrus stock in the last two years include Benjamin Shaw and Erin Powers Brennan. View Insider Buying and Selling for Covetrus.

Shares of CVET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVET stock can currently be purchased for approximately $15.01.

Covetrus has a market capitalization of $1.68 billion and generates $3.78 billion in revenue each year. Covetrus employs 5,000 workers across the globe.View Additional Information About Covetrus.

The official website for Covetrus is http://www.henryscheinvet.com/.

Covetrus' mailing address is 7 CUSTOM HOUSE STREET, PORTLAND ME, 04101. The company can be reached via phone at 888-280-2221 or via email at [email protected]